Training in Translating Neuroscience to Therapeutics (TTNT) at Rutgers University has openings for postdoctoral fellows, graduate students and MD/PhD students. This program is funded by a T32 institutional training grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). The Program Director is M. Maral Mouradian, MD, Director of the RWJMS Institute for Neurological Therapeutics.
The goal of this program is to provide scientists-in-training performing laboratory-based experiments the skills and competencies needed to advance their discoveries to treatments for neurological disorders. The program combines traditional coursework, seminars, conferences, a biostatistics curriculum, and an annual retreat, along with experiential learning through a series of apprenticeships with experts in fields that link scientific innovation with industry to advance laboratory discoveries to clinical trials.
Trainees will work in the laboratories of highly qualified neuroscientists and translational investigators employing multidisciplinary approaches to learn the principles of rigorous and reproducible research. Disease areas of interest include neurodegenerative and demyelinating disorders as well as others. They will also have mentors with expertise in medicinal chemistry, drug discovery and development, clinical research and trials, start-ups, and career opportunities.
Candidates must be either a U.S. citizen or permanent resident to qualify for appointment on the NIH T32 institutional training grant. Candidates should have a degree in a biomedical science discipline including neuroscience, molecular biology, cell biology, biochemistry, and pharmacology. Excellent oral and written communication skills are required. Salary is commensurate with NRSA Federal guidelines.
Interested individuals are encouraged to apply by submitting a curriculum vitae, a brief cover letter, and the contact information of three individuals who will provide letters of reference to:
Executive Assistant to the Director
RWJMS Institute for Neurological Therapeutics